PT-10
Identity unresolved — no invented CID/CAS/sequence; ≠ PT-141; TP10 is name-collision context only.
Editorial review:Evidence snapshot
This drawer marks papers. It is not a plan, a dose, or a source. A paper is a bounded report. It is not a protocol. Grades name the object. They are not a safety rating.
Identity lock. PT-10 could not be locked to a single, unambiguous peptide object from PubMed / PubChem in this pass. Shop-checklist labeling alone is not identity. Candidate collisions seen in open literature (e.g. transportan-10 / TP10 cell-penetrating peptide, CAS often cited 203716-10-3) are not accepted as proven for this label without sequence confirmation. PT-10 ≠ PT-141 (bremelanotide; separate drawer). PT-10 ≠ PT-20 (also unresolved). PubChem CID / formula / CAS: To be confirmed. This drawer marks the identity gap. It is not use advice.
Bottom line
Identity unresolved. Few or no object-matched PMIDs can be graded until sequence / CAS / CID are confirmed. Do not invent a drawer identity from adjacent “PT-” names.
Papers
No object-matched Primary papers are graded in this pack. If a future identity lock points to transportan-10 / TP10, that would be a new evidence pass with CPP membrane papers — not implied here.
Adjacent name collision (not graded as PT-10 proof)
PMID 37634858 — Bennett 2023
Tested: molecular-dynamics study of cell-penetrating peptide transportan-10 (TP10) membrane binding/insertion.
Does not show: that shop label “PT-10” is TP10; included only as a documented name-collision reminder.
What is not established
Any locked chemical identity for PT-10. Any human clinical efficacy. Equivalence to PT-141, PT-20, or transportan-10 without analytical confirmation. This drawer does not provide use advice, schedules, or sourcing.
Selected sources
Reported experiences
Reported topics are not established benefits.Risks and unknowns
Compare experiences with care.
Join the discussion
Verified members can contribute to compound conversations.